Three novel polymorphisms in the promoter region of the TIMP-3 gene are not associated with proliferative diabetic retinopathy in type 2 diabetes mellitus

被引:2
作者
Beránek, M
Kanková, K
Tschöplová, S
Kolár, P
Vácha, J
机构
[1] Masaryk Univ, Fac Med, Dept Pathophysiol, CS-66243 Brno, Czech Republic
[2] Masaryk Univ, Fac Med, Ctr Biostat & Anal, CS-66243 Brno, Czech Republic
[3] Masaryk Univ, Fac Sci, CS-66243 Brno, Czech Republic
[4] Univ Hosp Brno Bohunice, Dept Ophthalmol, Brno, Czech Republic
关键词
extracellular matrix; genetic polymorphism; T2DM; proliferative retinopathy; TIMP;
D O I
10.1076/ceyr.27.2.91.15954
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. Tissue inhibitor of metalloproteinase-3 (TIMP-3) is a member of the TIMP family of proteins, playing a significant role in the control of extracellular matrix remodelling. TIMP-3 might play a role in the regulation of retinal neovascularization during progression of diabetic retinopathy. Recently, three novel polymorphisms (-899T/A, -915A/G and -1296T/C) in the promoter region of the TIMP-3 gene have been identified. The aim of the study was to investigate a possible association of these polymorphisms with proliferative diabetic retinopathy (PDR) in type 2 diabetes mellitus (T2DM). Methods. Genotypes were detected by polymerase chain reaction and subsequent restriction with specific endonucleases. Allele frequencies were determined in an association study comprising three groups of subjects (n=371). Results. Linkage disequilibrium was found among the three polymorphisms (Pless than or equal to0.01). Allele frequencies did not differ between neither T2DM+PDR and T2DM non-PDR subjects (P>0.05) nor between all T2DM versus non-diabetic subjects (P>0.05). Conclusions. Polymorphisms in the promoter region of the TIMP-3 gene were not associated with the PDR in the Caucasian T2DM patients.
引用
收藏
页码:91 / 93
页数:3
相关论文
共 13 条
[1]  
AnandApte B, 1997, INVEST OPHTH VIS SCI, V38, P817
[2]  
[Anonymous], 1991, Ophthalmology, V98, P786
[3]   Identification of novel common polymorphisms in the promoter region of the TIMP-3 gene in Czech population [J].
Beránek, M ;
Kanková, K ;
Muzík, J .
MOLECULAR AND CELLULAR PROBES, 2000, 14 (04) :265-268
[4]   THE MATRIX METALLOPROTEINASES AND THEIR NATURAL INHIBITORS - PROSPECTS FOR TREATING DEGENERATIVE TISSUE-DISEASES [J].
DOCHERTY, AJP ;
OCONNELL, J ;
CRABBE, T ;
ANGAL, S ;
MURPHY, G .
TRENDS IN BIOTECHNOLOGY, 1992, 10 (06) :200-207
[5]   Presence of four tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, -3 and -4) in human fetal membranes [J].
Fortunato, SJ ;
Menon, R ;
Lombardi, SJ .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1998, 40 (06) :395-400
[6]   Matrix metalloproteinase expression in human retinal microvascular cells [J].
Grant, MB ;
Caballero, S ;
Tarnuzzer, RW ;
Bass, KE ;
Ljubimov, AV ;
Spoerri, PE ;
Galardy, RE .
DIABETES, 1998, 47 (08) :1311-1317
[7]   Localization of tissue inhibitor of metalloproteinases-3 in neurodegenerative retinal disease [J].
Jomary, C ;
Neal, MJ ;
Iwata, K ;
Jones, SE .
NEUROREPORT, 1997, 8 (9-10) :2169-2172
[8]  
Kumar R, 1998, INT J ONCOL, V12, P749
[9]  
Majka S, 2001, INVEST OPHTH VIS SCI, V42, P210
[10]   The regulation of neovascularization by matrix metalloproteinases and their inhibitors [J].
Moses, MA .
STEM CELLS, 1997, 15 (03) :180-189